| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 219 |
| 1 | TACROLIMUS | 199 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 185 |
| 3 | TACROLIMUS OINTMENT 0.1% | 185 |
| 4 | METHOTREXATE SODIUM | 164 |
| 5 | METHOTREXATE | 145 |
| 6 | PREDNISOLONE | 140 |
| 7 | PREDNISOLONE ORAL | 140 |
| 8 | PREDNISOLONE ORAL SOLUTION | 140 |
| 9 | MYCOPHENOLATE MOFETIL | 129 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUCYTOSINE | 24 | 0.0169 |
| 1 | AMPHOTERICIN B | 36 | 0.0028 |
| 2 | MYCOPHENILIC ACID | 59 | 0.0028 |
| 3 | REMDESIVIR | 30 | 0.0023 |
| 4 | VANCOMYCIN HYDROCHLORIDE | 17 | 0.0020 |
| 5 | LOMUSTINE | 5 | 0.0019 |
| 6 | MYCOPHENOLIC ACID | 63 | 0.0019 |
| 7 | BASILIXIMAB | 21 | 0.0018 |
| 8 | BARICITINIB | 5 | 0.0016 |
| 9 | TACROLIMUS OINTMENT 0.1% | 185 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 493 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 145 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 99 |
| 3 | Azole Antifungal [EPC] | 96 |
| 4 | Kinase Inhibitor [EPC] | 68 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 59 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 59 |
| 7 | Alkylating Drug [EPC] | 56 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 55 |
| 9 | Thalidomide Analog [EPC] | 42 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 24 | 0.0169 |
| 1 | Interleukin-5 Antagonist [EPC] | 6 | 0.0087 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 37 | 0.0029 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 59 | 0.0028 |
| 4 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 30 | 0.0023 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 9 | 0.0015 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 27 | 0.0012 |
| 7 | Polyene Antifungal [EPC] | 40 | 0.0010 |
| 8 | Selective T Cell Costimulation Blocker [EPC] | 4 | 0.0008 |
| 9 | Human Immunoglobulin G [EPC] | 17 | 0.0008 |